Amphastar Pharma (AMPH) Tops Q3 EPS by 3c

Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of $0.10, $0.03 better than the analyst estimate of $0.07. Revenue for the quarter came in at $80.1 million versus the consensus estimate of $78.53 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• Freedom Broker Upgrades Morgan Stanley (MS) to Buy
• Nolan’s ’The Odyssey’ eyes $200M global debut, benefiting IMAX and theater stocks